Dr. Reddy's Laboratories Limited (DRREDDY) — Board Meeting | 24 July 2025(3 announcements)
Dr. Reddy's Laboratories shareholders approved the appointment of Makarand M Joshi & Co. as secretarial auditors for a five-year term starting April 1, 2025, at the 41st AGM on July 24, 2025, fulfilling SEBI Regulation 30 disclosure requirements.
Dr. Reddy's Laboratories shareholders approved the re-appointment of Mr. G V Prasad as Whole-Time Director and Co-Chairman & Managing Director for five years starting January 30, 2026, at the 41st Annual General Meeting on July 24, 2025, following board recommendation and regulatory compliance requirements.
Dr. Reddy's Laboratories held its 41st Annual General Meeting on July 24, 2025 via video conferencing, adopting audited FY2025 financial statements, declaring an Rs. 8 dividend per share, and reappointing G V Prasad as Whole-time Director and Co-Chairman. Shareholders approved all six resolutions with overwhelming majorities, including cost auditor remuneration and secretarial auditor appointment, following remote e-voting conducted from July 20-23, 2025.
About Dr. Reddy's Laboratories Limited (DRREDDY)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
📡 Get AI alerts when DRREDDY files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track DRREDDY — Free💡 Ask AI about this filing
📊 More DRREDDY filings
- Announcement — 13 August 2026 Dr. Reddy's Laboratories announced the resignation of CEO Deepak Sapra from the Senior Management Pe...
- Announcement — 7 August 2026 Dr. Reddy's Laboratories announced termination of its distribution agreement with Novartis India eff...
- Announcement — 1 August 2026 Dr. Reddy's Laboratories announced that the U.S. FDA approved its rituximab biosimilar for the U.S. ...
- Announcement — 29 July 2026 Dr. Reddy's Laboratories announced that the US FDA completed a Pre-Approval Inspection and GMP check...
- Announcement — 29 July 2026 Dr. Reddy's Laboratories clarified on July 29, 2026 that a Business Standard news article about Thai...
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
Editorial & Data Transparency Notice
This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.
📡 Get AI alerts when DRREDDY files new disclosures
Track DRREDDY filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track DRREDDY — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research